Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–9 of 9 results
Advanced filters: Author: John Wrangle Clear advanced filters
    • John H. McD. Whitaker
    Books & Arts
    Nature
    Volume: 347, P: 28-29
  • Pension managers may be warming up to the idea that much needed high rewards for their funds could come from investing in the high risk private equity biotech sector.

    • John Ransom
    News
    Nature Biotechnology
    Volume: 24, P: 600
  • Australia's universities begin this month an academic year that will see them well on the way towards a unified system of higher education. Hopes that an election later in the year will bring a change of course, probably misplaced, are unlikely to be fulfilled. But nobody can guess what the consequences will be except that they will be profound.

    • John Maddox
    Comments & Opinion
    Nature
    Volume: 343, P: 203-206
  • In mouse models of pulmonary metastasis, adjuvant epigenetic therapy targeting myeloid-derived suppressor cells disrupts the premetastatic microenvironment after resection of primary tumours and inhibits the dissemination of residual tumour cells.

    • Zhihao Lu
    • Jianling Zou
    • Malcolm V. Brock
    Research
    Nature
    Volume: 579, P: 284-290
  • This paper describes molecular subtypes of cervical cancers, including squamous cell carcinoma and adenocarcinoma clusters defined by HPV status and molecular features, and distinct molecular pathways that are activated in cervical carcinomas caused by different somatic alterations and HPV types.

    • Robert D. Burk
    • Zigui Chen
    • David Mutch
    ResearchOpen Access
    Nature
    Volume: 543, P: 378-384
  • An analysis of more than 50 collaborations shows the secrets of success, write Joel Cutcher-Gershenfeld and colleagues from the Stakeholder Alignment Collaborative.

    • Joel Cutcher-Gershenfeld
    • Karen S. Baker
    • Ilya Zaslavsky
    Comments & Opinion
    Nature
    Volume: 543, P: 615-617